Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients

Breast

Volumn 24, Issue 3, 2015, Pages 272-277

  Sorin, T ^a,m   Fyad, J P ^a   Delay, E ^b   Rouanet, P ^c   Rimareix, F ^d   Houpeau, J L ^e   Classe, J M ^f   Garrido, I ^g   Tunon De Lara, C ^h   Dauplat, J ⁱ   Bendavid, C ^j   Houvenaeghel, G ^k   Clough, K B ^l   Sarfati, I ^l   Leymarie, N ^d   Trudel, M ^e   Salleron, J ^a   Guillemin, F ^a   Oldrini, G ^a   Brix, M ^a,m   Dolivet, G ^a   Simon, E ^m   Verhaeghe, J L ^a   Marchal, F ^a,n   more..

^a Service d'anatomie pathologique Institut de cancérologie de Lorraine   (France)

^b CENTRE LÉON BÉRARD   (France)

^c CENTRE VAL D AURELLE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Oscar Lambret Centre   (France)

^f UMR INSERM U892 CNRS 6299   (France)

^g Department of Surgical Oncology   (France)

^h Bergonie Cancer Institute   (France)

ⁱ Jean Perrin Centre   (France)

^j Eugène Marquis Hospital   (France)

^k Medical Oncology Unit   (France)

^l Institut du Sein   (France)

^m UNIVERSITY HOSPITAL OF NANCY   (France)

ⁿ UNIVERSITÉ DE LORRAINE   (France)

more..

Author keywords

Breast neoplasms; Breast reconstruction; Incidence study; Mammoplasty; Reconstructive surgical procedures

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; BREAST REDUCTION; CANCER RADIOTHERAPY; CONTRALATERAL REDUCTION MAMMAPLASTY; FEMALE; HORMONAL THERAPY; HUMAN; INCIDENTAL FINDING; INTRADUCTAL CARCINOMA; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; MEDICAL DECISION MAKING; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME; AGED; BREAST NEOPLASMS; BREAST RECONSTRUCTION; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; CLINICAL TRIAL; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; NEOPLASMS, UNKNOWN PRIMARY; PATHOLOGY; SECONDARY; SEGMENTAL MASTECTOMY; STATISTICS AND NUMERICAL DATA;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; INCIDENCE; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; RETROSPECTIVE STUDIES;

EID: 84937642961     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2015.02.033     Document Type: Article

References (28)

1. Arveux P., Colonna M., Molinié F., Trétarre B. Estimated incidence of cancer and cancer mortality in France between 1980 and 2012. Part 1 2013, Institut de veille sanitaire.
2. Alderman A.K., Hawley S.T., Janz N.K., et al. Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population-based study. JClin Oncol 2009, 27:5325-5330.
3. Kruper L., Holt A., Xu X.X., et al. Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Ann Surg Oncol 2011, 18:2158-2165.
4. Kheirelseid E.A., Jumustafa H., Miller N., et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics. Breast Cancer Res Treat 2011, 126:131-140.
5. Beinart G., Gonzalez-Angulo A.M., Broglio K., et al. Clinical course of 771 patients with bilateral breast cancer: characteristics associated with overall and recurrence-free survival. Clin Breast Cancer 2007, 7:867-874.
6. Robinson E., Rennert G., Rennert H.S., Neugut A.I. Survival of first and second primary breast cancer. Cancer 1993, 1(71):172-176.
7. Colwell A.S., Kukreja J., Breuing K.H., Lester S., Orgill D.P. Occult breast carcinoma in reduction mammapasty specimens - 14 year experience. Plast Rescontr Surg 2004, 113:1984-1988.
8. Slezak S., Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties - preserving the choice of lumpectomy. Plast Reconst Surg 2011, 127:525-530.
9. Hassan F.E., Pacifico M.D. Should we be analysing breast reduction specimens ?A systematic analysis of over 1000 consecutive cases. Aesth Plast Surg 2012, 36:1105-1113.
10. Rietjens M., Petit J.Y., Contesso G., Bertin F., Gilles R. The role of reduction mammaplasty in oncology. Eur J Plast Surg 1997, 20:246-250.
11. Goyal A., Coulson S.G., Wu J.M., Suvarna S.K., Reed M.W.R., Caddy C.M. Occult breast carcinoma in breast reduction specimens in european women. Brest Cancer Res Treat 2011, 128:749-753.
12. Sorin T., Fyad J.P., Pujo J., et al. Incidence of occult contralateral carcinomas of the breast following mastoplasty aimed at symmetrization. Ann Chir Plast Esthet 2014, 59:e21-28.
13. Snyderman R.K., Lizardo J.G. Statistical study of malignancies found before, during, or after routine breast plastic operations. Plast Reconstr Surg 1960, 25:253-256.
14. Pitanguy I., Torres E.T. Histological aspects of mammary gland tissue in cases of plastic surgery. Br J Plast Surg 1964, 17:297-302.
15. Pitanguy I., Torres E., Salgado F., Pires Viana G.A. Breast pathology and reduction mammaplasty. Plast Reconstr Surg 2005, 115:729-734.
16. Boice J.D., Persson I., Brinton L.A., Hober M., McLaughlin J.K., Blot W.J., et al. Breast cancer following breast reduction surgery in Sweden. Plast Reconstr Surg 2000, 106:755-762.
17. Jensen D.A., Murphy M., Kind G.M., Sands K. Breast cancer in reduction mammaplasty: case reports and a survey of plastic surgerons. Plast Reconstr Surg 1998, 101:361-364.
18. Titley O.G., Armstrong A.P., Christie J.L., Fatah M.F. Pathological findings in breast reduction surgery. Br J Plast Surg 1996, 49:447-451.
19. Tang C.L., Brown M.H., Levine R., Sloan M., Chong N., Holowaty E. Breast cancer found at the time of breast reduction. Plast Reconstr Surg 1999, 103:1682-1686.
20. Colleau M., Magalon G., Bonnier P. Cancer du sein diagnostiqué par la réduction mammaire. Étude rétrospective sur une période de trois ans. Ann Chir Plast Esteth 2005, 50:127-133.
21. Dotto J., Kluk M., Geramizadeh B. Tavassoli. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases. Int J Surg Patho 2008, 16:25-30.
22. Arpino G., Bardou V.J., Clark G.M., Elledge R.M. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004, 6:R149-R156.
23. Wolters R., Wöckel A., Janni W., et al. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients. Breast Cancer Res Treat 2013, 142:579-590.
24. Lynch S.P., Lei X., Chavez-MacGregor M., et al. Multifocality and multicentricity in breast cancer and survival outcomes. Ann Oncol 2012, 23:3063-3069.
25. Yerushalmi R., Kennecke H., Woods R., Olivotto I.A., Speers C., Gelmon K.A. Does multicentric/multifocal breast cancer differ from unifocal breast cancer? an analysis of survival and contralateral breast cancer incidence. Breast Cancer Res Treat 2009, 117:365-370.
26. Rodriguez Fernandez J., Martella S., Trifirò G., et al. Sentinel node biopsy in patients with previous breast aesthetic surgery. Ann Surg Oncol 2009, 16:989-992.
27. Golshan M., Lesnikoski B.A., Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg 2006, 72:397-400.
28. Kiluk J.V., Kaur P., Meade T., et al. Effects of prior augmentation and reduction mammoplasty to sentinel node lymphatic mapping in breast cancer. Breast J 2010, 16:598-602.